Home › Acute Myeloid Leukemia › New York › Staten Island
Acute Myeloid Leukemia clinical trials in Staten Island, NY
14 studies for Acute Myeloid Leukemia are looking for participants at sites in and around Staten Island (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
RecruitingPhase 2
- Memorial Sloan Kettering Monmouth, Middletown · 12 mi away
Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
RecruitingPhase 1
- Memorial Sloan Kettering Monmouth, Middletown · 12 mi away
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
RecruitingPhase 2
- Memorial Sloan Kettering Monmouth, Middletown · 12 mi away
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
RecruitingPhase 2
- Memorial Sloan Kettering Monmouth, Middletown · 12 mi away
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
RecruitingPhase 2
- Memorial Sloan Kettering Monmouth, Middletown · 12 mi away
A Study of CRD3874-SI in People With Leukemia
RecruitingPhase 1
- Memorial Sloan Kettering Monmouth (All protocol activities), Middletown · 12 mi away
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
RecruitingPhase 2
- Memorial Sloan Kettering Monmouth, Middletown · 12 mi away
A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia
RecruitingPhase 2
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown · 12 mi away
A Study of Revumenib and Mezigdomide in People With Leukemia
RecruitingPhase 1/2
- Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown · 12 mi away
A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia
RecruitingPhase 1
- Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown · 12 mi away
A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML)
RecruitingPhase 1
- Memorial Sloan Kettering Monmouth, Middletown · 12 mi away
A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia
RecruitingPhase 1
- Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown · 12 mi away
A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia
RecruitingPhase 1
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown · 12 mi away
A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)
RecruitingPhase 2
- Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown · 12 mi away
About Acute Myeloid Leukemia
Acute Myeloid Leukemia (AML) is a cancer of the white blood cells. AML usually gets worse quickly if it is not treated. Read more.
More about Acute Myeloid Leukemia on MedlinePlus
Acute Myeloid Leukemia trials in other cities
- Houston, TX85 studies
- New York City, NY51 studies
- Boston, MA44 studies
- Seattle, WA41 studies
- Baldwin Park, CA40 studies
- Columbus, OH35 studies
- Philadelphia, PA34 studies
- Durham, NC33 studies
- Atlanta, GA31 studies
- Tampa, FL29 studies
- Chicago, IL26 studies
- Portland, OR25 studies
Other studies in Staten Island
- Breast Cancer40 studies
- Non-Small Cell Lung Cancer19 studies
- Prostate Cancer16 studies
- Multiple Myeloma13 studies
- Lung Cancer12 studies
- Bladder Cancer11 studies
- Cancer (all types)11 studies
- Endometrial Cancer11 studies
- Metastatic Cancer10 studies
- Ovarian Cancer9 studies
- Head and Neck Squamous Cell Carcinoma9 studies
- Lymphoma8 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.